ACOG Released Clinical Toolkit for Perimenopause Care
The American College of Obstetricians and Gynecologists issued new guidance to manage hormonal shifts during midlife.
Updated on Sept. 23, 2026 in Women’s Health
Live Poll
Do you trust clinical guidelines to improve the care women receive during the menopause transition?
The American College of Obstetricians and Gynecologists has published a clinical toolkit in the journal Obstetrics & Gynecology to standardize perimenopause management. The document frames perimenopause as a distinct hormonal continuum that requires proactive clinical guidance.
Why it matters
Perimenopause is physiologically distinct and clinically complex compared to menopause, yet clinicians previously lacked a unified framework for care. Anticipatory guidance is now recommended to address symptoms before they become severe.
Perimenopause typically begins at a median age of 47, though the onset can occur before age 45. Researchers emphasize that currently, no medical therapies hold FDA approval specifically for this transitional stage.
The players
The American College of Obstetricians and Gynecologists
This is a professional association of physicians and surgeons who specialize in the fields of obstetrics and gynecology.
The details
The toolkit advises clinicians to evaluate bleeding patterns, symptoms, and medical risk factors as part of routine midlife healthcare assessments. It outlines two primary treatment pathways, involving either ovarian suppression through hormonal contraception or systemic estrogen supplementation.
Timeline
The Stages of Reproductive Aging Workshop +10 system was introduced in 2012.
The clinical toolkit was published in Obstetrics & Gynecology on September 23, 2026.
The Big Picture
This toolkit extends the diagnostic foundation laid by the 2012 Stages of Reproductive Aging Workshop +10 system into active clinical management. It updates clinical practice by applying standardized, hormonal-continuum frameworks to the previously complex landscape of midlife care.
Patients may now receive proactive guidance for hormonal shifts during routine midlife checkups rather than waiting for symptoms to intensify. This approach allows clinicians to integrate contraceptive needs with hormonal therapy options to better manage health throughout the transition.
The takeaway
Patients experiencing midlife hormonal fluctuations should discuss their symptoms and medical history with their doctors early to determine if hormonal contraception or estrogen therapy is appropriate. Because this transition is a dynamic physiological process, ongoing monitoring of health markers is essential for long-term well-being.
Further reading
For more information on clinical standards in midlife care, visit the Women’s Health section.
Source note: This article includes information reported by Medscape.
Live Poll
Do you trust clinical guidelines to improve the care women receive during the menopause transition?
